Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer
Clinical trial NCT00295035 · UNKNOWN
Trial details
- NCT number
- NCT00295035
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.